结果页面 12，板块：医疗保健，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
医疗保健 (2611)
- {{item.name}}
- 所有版块
- 医疗保健 (2611)
生物技术 (2611)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Ionis Pharmaceuticals, Inc. ISI.F | $30.65 33.5 USD |
+0.46
|
$4.93B 5.39B USD | $755 825.32 USD | $30.65 33.5 USD | $30.65 33.5 USD | $4.93B 5.39B USD | 0 | -$2.6 -2.8 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $90,400 68.24 USD |
+0.78
|
$7.08T 5.34B USD | $153.53K 115.89 USD | $89,600 67.63 USD | $91,400 68.99 USD | $7.08T 5.34B USD | 0 | $0 0 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Zealand Pharma A/S ZLDPF | $71.11 — |
0
|
$5.17B — | $817 — | $69.57 — | $71.11 — | $5.17B — | 0 | -$2.65 — | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $12.12 2.46 USD |
+10.48
|
$23.99B 4.86B USD | $760 154.04 USD | $11.74 2.38 USD | $12.12 2.46 USD | $23.99B 4.86B USD | 0 | -$0.74 -0.1 USD | |
| Biocon Limited BIOCON.BO | $330.1 3.99 USD |
-0.17
|
$395.48B 4.78B USD | $72.58K 878.09 USD | $327.75 3.97 USD | $332.6 4.02 USD | $395.48B 4.78B USD | 39.06 | $8.45 0.1 USD | |
| Vaxcyte, Inc. 5VA.F | $29 31.7 USD |
+2.84
|
$4.28B 4.68B USD | $160 174.9 USD | $29 31.7 USD | $29 31.7 USD | $4.28B 4.68B USD | 0 | -$3.39 -3.7 USD | |
| Vaxcyte, Inc. 5VA.MU | $30.2 33.01 USD |
+1.34
|
$4.22B 4.62B USD | $0 0 USD | $30.2 33.01 USD | $30.2 33.01 USD | $4.22B 4.62B USD | 0 | -$3.44 -3.7 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $35.45K 5.2K USD | $182.85 26.81 USD | $185.7 27.23 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $58 63.4 USD |
+3.57
|
$3.92B 4.28B USD | $20 21.86 USD | $58 63.4 USD | $58 63.4 USD | $3.92B 4.28B USD | 0 | -$2.36 -2.5 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.8 8.53 USD |
+0.65
|
$3.92B 4.28B USD | $170 185.83 USD | $7.8 8.53 USD | $7.8 8.53 USD | $3.92B 4.28B USD | 22.94 | $0.34 0.37 USD | |
| Akero Therapeutics, Inc. 0K4.F | $47.09 51.48 USD |
+1.97
|
$3.85B 4.21B USD | $260 284.22 USD | $47.09 51.48 USD | $47.09 51.48 USD | $3.85B 4.21B USD | 0 | -$3.21 -3.5 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $1,222 72.36 USD |
0
|
$70.77B 4.19B USD | $0 0 USD | $1,222 72.36 USD | $1,222 72.36 USD | $70.77B 4.19B USD | 5.16 | $236.58 14.01 USD | |
| Zealand Pharma A/S 0NZU.IL | $477.7 70.04 USD |
+2.95
|
$28.48B 4.18B USD | $17.78K 2.61K USD | $467 68.47 USD | $475.5 69.72 USD | $28.48B 4.18B USD | 0 | -$15.13 -2.2 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Genscript Biotech GNNSF | $1.7 — |
0
|
$4.06B — | $1K — | $1.7 — | $1.7 — | $4.06B — | 0 | -$0.08 — | |
| Sarepta Therapeutics, Inc. AB3A.F | $34.38 37.58 USD |
+0.12
|
$3.7B 4.04B USD | $50 54.66 USD | $34.38 37.58 USD | $34.38 37.58 USD | $3.7B 4.04B USD | 0 | -$2.3 -2.5 USD | |
| Zai Lab Limited 1ZL.F | $31.6 34.54 USD |
+1.28
|
$3.66B 4.01B USD | $230 251.42 USD | $31.6 34.54 USD | $31.6 34.54 USD | $3.66B 4.01B USD | 0 | -$2.16 -2.3 USD | |
| Merus N.V. 2GH.F | $48.4 52.91 USD |
-0.82
|
$3.63B 3.96B USD | $200 218.63 USD | $47.8 52.25 USD | $48.4 52.91 USD | $3.63B 3.96B USD | 0 | -$3.66 -4.0008 USD | |
| Genscript Biotech Corporation G51.F | $1.5 1.64 USD |
+1.45
|
$3.59B 3.93B USD | $2.77K 3.03K USD | $1.5 1.64 USD | $1.5 1.64 USD | $3.59B 3.93B USD | 0 | -$0.07 -0.07 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Krystal Biotech, Inc. 4KB.F | $115.3 126.04 USD |
+0.57
|
$3.48B 3.8B USD | $190 207.7 USD | $115.3 126.04 USD | $115.3 126.04 USD | $3.48B 3.8B USD | 31.85 | $3.62 3.96 USD | |
| Krystal Biotech, Inc. 4KB.SG | $115.3 126.04 USD |
+0.35
|
$3.47B 3.79B USD | $0 0 USD | $115.3 126.04 USD | $115.3 126.04 USD | $3.47B 3.79B USD | 31.76 | $3.63 3.97 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Cytokinetics, Incorporated KK3A.F | $27.8 30.39 USD |
+0.72
|
$3.39B 3.71B USD | $150 163.97 USD | $27.8 30.39 USD | $27.8 30.39 USD | $3.39B 3.71B USD | 0 | -$4.59 -5.01 USD | |
| Camurus AB (publ) 7CA.F | $57.7 63.07 USD |
-0.86
|
$3.39B 3.7B USD | $1.22K 1.34K USD | $57.7 63.07 USD | $57.7 63.07 USD | $3.39B 3.7B USD | 68.69 | $0.84 0.92 USD | |
| Scholar Rock Holding Corporation 2QK.F | $29.6 32.36 USD |
+11.28
|
$3.16B 3.45B USD | $20 21.86 USD | $29.6 32.36 USD | $29.6 32.36 USD | $3.16B 3.45B USD | 0 | -$2 -2.1 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.57 20.3 USD |
-1.88
|
$3.15B 3.45B USD | $100 109.31 USD | $18.57 20.3 USD | $18.57 20.3 USD | $3.15B 3.45B USD | 15.22 | $1.22 1.33 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $32.2 35.2 USD |
+1.26
|
$3.11B 3.4B USD | $54 59.03 USD | $32.2 35.2 USD | $32.2 35.2 USD | $3.11B 3.4B USD | 0 | -$5.03 -5.4 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| Syngene International Limited SYNGENE.BO | $645.7 7.81 USD |
-0.21
|
$259.42B 3.14B USD | $10.68K 129.26 USD | $642.15 7.77 USD | $648 7.84 USD | $259.42B 3.14B USD | 52.36 | $12.33 0.15 USD | |
| VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $54.9 60.01 USD |
-0.81
|
$2.81B 3.07B USD | $19 20.77 USD | $54.9 60.01 USD | $54.9 60.01 USD | $2.81B 3.07B USD | 19.89 | $2.76 3.02 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $22.15 24.21 USD |
-0.05
|
$2.75B 3.01B USD | $500 546.57 USD | $22.15 24.21 USD | $22.15 24.21 USD | $2.75B 3.01B USD | 16.16 | $1.37 1.5 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $28.2 30.83 USD |
+0.71
|
$2.72B 2.97B USD | $60 65.59 USD | $28.2 30.83 USD | $28.2 30.83 USD | $2.72B 2.97B USD | 0 | -$3.33 -3.6 USD | |
| ImmunityBio, Inc. 26CA.F | $2.77 3.03 USD |
+9.71
|
$2.66B 2.91B USD | $4K 4.37K USD | $2.51 2.75 USD | $2.86 3.12 USD | $2.66B 2.91B USD | 0 | -$0.45 -0.4 USD | |
| Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Viking Therapeutics, Inc. 1VT.F | $22.92 25.05 USD |
-4.44
|
$2.61B 2.85B USD | $50 54.66 USD | $22.92 25.05 USD | $22.93 25.06 USD | $2.61B 2.85B USD | 0 | -$1.06 -1.1 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
| ABL Bio Inc. 298380.KQ | $75,800 57.22 USD |
-0.79
|
$3.64T 2.75B USD | $826.98K 624.24 USD | $75,100 56.69 USD | $78,900 59.56 USD | $3.64T 2.75B USD | 0 | $0 0 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $46,150 34.84 USD |
0
|
$3.55T 2.68B USD | $127.84K 96.5 USD | $45,550 34.38 USD | $46,950 35.44 USD | $3.55T 2.68B USD | 0 | $0 0 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S 0DPB.IL | $180.1 26.41 USD |
-1.15
|
$16.9B 2.48B USD | $8.12K 1.19K USD | $179.48 26.31 USD | $181.45 26.6 USD | $16.9B 2.48B USD | 12.78 | $14.09 2.07 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $16.05 17.55 USD |
+3.2
|
$2.18B 2.39B USD | $240 262.35 USD | $16.05 17.55 USD | $16.05 17.55 USD | $2.18B 2.39B USD | 0 | -$1.52 -1.6 USD | |
| Ascentage Pharma Group International 36X.F | $6.1 6.67 USD |
+0.83
|
$2.17B 2.37B USD | $200 218.63 USD | $6.05 6.61 USD | $6.1 6.67 USD | $2.17B 2.37B USD | 0 | -$0.16 -0.1 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $26.8 29.3 USD |
+0.75
|
$2.14B 2.33B USD | $40 43.73 USD | $26.8 29.3 USD | $26.8 29.3 USD | $2.14B 2.33B USD | 0 | -$2.82 -3.08 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $38.2 41.76 USD |
+2.14
|
$2.05B 2.24B USD | $26 28.42 USD | $38 41.54 USD | $38.2 41.76 USD | $2.05B 2.24B USD | 0 | -$1.38 -1.5 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $9.54 10.42 USD |
+0.74
|
$2.03B 2.22B USD | $190 207.7 USD | $9.54 10.42 USD | $9.54 10.42 USD | $2.03B 2.22B USD | 0 | -$0.23 -0.2 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $14.34 15.68 USD |
-1.48
|
$2B 2.18B USD | $80 87.45 USD | $14.34 15.68 USD | $14.34 15.68 USD | $2B 2.18B USD | 0 | -$1.1 -1.2 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S BVNKF | $27.5 — |
0
|
$2.16B — | $668 — | $27.3 — | $27.5 — | $2.16B — | 10.70 | $2.57 — | |
| Galapagos NV G1LP34.SA | $7.87 1.6 USD |
-2.48
|
$10.37B 2.1B USD | $5 1.01 USD | $7.84 1.59 USD | $7.87 1.6 USD | $10.37B 2.1B USD | 0 | -$0.9 -0.1 USD | |
| Vericel Corporation ATQP.F | $37.8 41.32 USD |
+0.53
|
$1.91B 2.09B USD | $130 142.11 USD | $37.8 41.32 USD | $37.8 41.32 USD | $1.91B 2.09B USD | 756.00 | $0.05 0.05 USD | |
| Bavarian Nordic A/S BV3.F | $24.1 26.34 USD |
+1.26
|
$1.91B 2.09B USD | $855 934.63 USD | $23.43 25.61 USD | $24.1 26.34 USD | $1.91B 2.09B USD | 10.85 | $2.22 2.43 USD | |
| Denali Therapeutics Inc. 4DN.MU | $12.51 13.68 USD |
0
|
$1.86B 2.04B USD | $0 0 USD | $12.51 13.68 USD | $12.51 13.68 USD | $1.86B 2.04B USD | 0 | -$2.33 -2.5 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.39 13.54 USD |
-1.27
|
$1.84B 2.01B USD | $200 218.63 USD | $12.39 13.54 USD | $12.39 13.54 USD | $1.84B 2.01B USD | 0 | -$2.36 -2.5 USD | |
| Veracyte, Inc. 12V.F | $23.2 25.36 USD |
-3.33
|
$1.82B 1.99B USD | $50 54.66 USD | $23.2 25.36 USD | $23.2 25.36 USD | $1.82B 1.99B USD | 61.05 | $0.38 0.42 USD | |
| BioArctic AB (publ) 0RV2.IL | $200 19.52 USD |
0
|
$20.01B 1.95B USD | $46.15K 4.5K USD | $199.9 19.51 USD | $199.9 19.51 USD | $20.01B 1.95B USD | 65.14 | $3.07 0.3 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $90 98.38 USD |
-0.55
|
$1.78B 1.94B USD | $20 21.86 USD | $90 98.38 USD | $90 98.38 USD | $1.78B 1.94B USD | 0 | -$6.38 -6.9 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $29.2 31.92 USD |
-0.68
|
$1.72B 1.88B USD | $54 59.03 USD | $29.2 31.92 USD | $29.2 31.92 USD | $1.72B 1.88B USD | 2.87 | $10.15 11.1 USD | |
| Everest Medicines Limited 6HN.F | $5.1 5.57 USD |
0
|
$1.72B 1.88B USD | $212 231.74 USD | $5.1 5.57 USD | $5.1 5.57 USD | $1.72B 1.88B USD | 0 | -$0.39 -0.4 USD | |
| Galapagos GLPGF | $27.5 — |
0
|
$1.85B — | $200 — | $27.5 — | $27.5 — | $1.85B — | 0 | -$3.12 — | |
| Mesoblast MEOBF | $1.44 — |
0
|
$1.83B — | $170 — | $1.44 — | $1.44 — | $1.83B — | 0 | -$0.09 — | |
| Immunocore Holdings plc 6YG.MU | $33.4 36.51 USD |
+1.83
|
$1.67B 1.83B USD | $0 0 USD | $32.8 35.85 USD | $32.8 35.85 USD | $1.67B 1.83B USD | 0 | -$1.32 -1.4 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| IDEAYA Biosciences, Inc. 30J.SG | $18 19.68 USD |
0
|
$1.66B 1.82B USD | $0 0 USD | $18 19.68 USD | $18 19.68 USD | $1.66B 1.82B USD | 0 | -$3.19 -3.4 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $18.4 20.11 USD |
0
|
$1.66B 1.82B USD | $115 125.71 USD | $18.4 20.11 USD | $18.4 20.11 USD | $1.66B 1.82B USD | 0 | -$3.19 -3.4 USD | |
| Pharma Mar PHMMF | $103.6 — |
0
|
$1.79B — | $8.57K — | $103.6 — | $103.6 — | $1.79B — | 79.69 | $1.3 — | |
| Immunocore Holdings plc 6YG.F | $32.4 35.42 USD |
-1.22
|
$1.63B 1.78B USD | $149 162.88 USD | $32.4 35.42 USD | $33.4 36.51 USD | $1.63B 1.78B USD | 0 | -$0.38 -0.4 USD | |
| Galapagos NV GLPG.VI | $24.54 26.83 USD |
-0.65
|
$1.62B 1.77B USD | $0 0 USD | $24.46 26.74 USD | $24.54 26.83 USD | $1.62B 1.77B USD | 0 | -$2.73 -2.9 USD | |
| BioArctic AB (publ) B9A.F | $18.15 19.84 USD |
-0.17
|
$1.62B 1.77B USD | $500 546.57 USD | $18.15 19.84 USD | $18.15 19.84 USD | $1.62B 1.77B USD | 19.51 | $0.93 1.02 USD | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Genus GENSF | $26.6 — |
0
|
$1.77B — | $5.42K — | $26.6 — | $26.6 — | $1.77B — | 0 | -$0.09 — | |
| Galapagos NV GXE.F | $24.34 26.61 USD |
-0.49
|
$1.62B 1.77B USD | $150 163.97 USD | $24.34 26.61 USD | $24.52 26.8 USD | $1.62B 1.77B USD | 0 | -$2.74 -2.9 USD | |
| Amicus Therapeutics, Inc. AM6.F | $5.15 5.63 USD |
-2.83
|
$1.61B 1.76B USD | $47 51.38 USD | $5.15 5.63 USD | $5.15 5.63 USD | $1.61B 1.76B USD | 0 | -$0.08 -0.08 USD | |
| Galapagos NV GXEA.F | $24.4 26.67 USD |
-1.61
|
$1.61B 1.76B USD | $4 4.37 USD | $24.4 26.67 USD | $24.4 26.67 USD | $1.61B 1.76B USD | 0 | -$2.78 -3.03 USD | |
| PeptiDream PPTDF | $13.53 — |
0
|
$1.75B — | $2.27K — | $13.53 — | $13.53 — | $1.75B — | 16.91 | $0.8 — | |
| Pharma Mar, S.A. PMRA.F | $91.55 100.08 USD |
+1.27
|
$1.58B 1.73B USD | $410 448.19 USD | $91.55 100.08 USD | $91.55 100.08 USD | $1.58B 1.73B USD | 82.47 | $1.11 1.21 USD | |
| Genus plc GBE.F | $23.4 25.58 USD |
0
|
$1.55B 1.69B USD | $610 666.81 USD | $23.4 25.58 USD | $23.4 25.58 USD | $1.55B 1.69B USD | 0 | -$0.07 -0.07 USD | |
| Pharma Mar, S.A. 0RC6.IL | $85.03 92.94 USD |
-7.05
|
$1.54B 1.68B USD | $1.82K 1.99K USD | $82.63 90.32 USD | $93 101.66 USD | $1.54B 1.68B USD | 76.59 | $1.11 1.21 USD | |
| BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.45B 1.65B USD | 0 | $0 0 USD | |
| Biotest Aktiengesellschaft BIO3.F | $30.2 33.01 USD |
+1.34
|
$1.42B 1.55B USD | $600 655.88 USD | $29.6 32.36 USD | $30.2 33.01 USD | $1.42B 1.55B USD | 0 | -$0.62 -0.6 USD | |
| Adaptive Biotechnologies Corporation 1HM.F | $9 9.84 USD |
+4.43
|
$1.4B 1.53B USD | $100 109.31 USD | $8.53 9.32 USD | $9 9.84 USD | $1.4B 1.53B USD | 0 | -$0.79 -0.8 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $29.8 32.58 USD |
0
|
$1.4B 1.53B USD | $0 0 USD | $29.8 32.58 USD | $30 32.79 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO.F | $42.2 46.13 USD |
0
|
$1.4B 1.53B USD | $30 32.79 USD | $42.2 46.13 USD | $42.2 46.13 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| Liquidia Corporation LT4.F | $15.62 17.07 USD |
+2.23
|
$1.38B 1.51B USD | $1.45K 1.58K USD | $15.62 17.07 USD | $15.62 17.07 USD | $1.38B 1.51B USD | 0 | -$1.46 -1.5 USD | |
| Liquidia Corporation LT4.MU | $15.62 17.07 USD |
+2.23
|
$1.38B 1.51B USD | $0 0 USD | $15.62 17.07 USD | $15.62 17.07 USD | $1.38B 1.51B USD | 0 | -$1.46 -1.5 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.38 1.51 USD |
0
|
$1.38B 1.51B USD | $333 364.01 USD | $1.38 1.51 USD | $1.41 1.54 USD | $1.38B 1.51B USD | 0 | -$0.19 -0.2 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.2 46.13 USD |
-0.94
|
$1.38B 1.51B USD | $175 191.3 USD | $42.2 46.13 USD | $43 47 USD | $1.38B 1.51B USD | 0 | -$0.64 -0.6 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||